Chicago, IL, June 26, 2024 (GLOBE NEWSWIRE) -- We are pleased to announce that the remaining 4 sessions from the World Sepsis Spotlight: Unmet Need in Sepsis Diagnosis and Treatment, hosted by the Global Sepsis Alliance (GSA) and the Physician-Patient Alliance for Health & Safety (PPAHS) have been accredited by PPAHS for continuing medical education (CME) credits. Participants can earn continuing medical education credits by accessing the Spotlight sessions . We are also thrilled to confirm that CME credits for the 2024 WSC Spotlight will be issued free of charge.
PPAHS would like to once again thank for their unrestricted educational grant. Inflammatix is a pioneering diagnostics company based in Sunnyvale, California, USA, and is developing innovative diagnostics that rapidly read a patient’s immune system to improve patient care and reduce major public health burdens. Thanks to generous grants from and others, PPAHS can provide quality clinical educational content.
The 2024 WSC Spotlight featured sessions by over 40 internationally renowned speakers, panelists, and moderators. In the final 4 sessions now available for CME, they covered: The sepsis CME program can now be viewed , enabling healthcare professionals to complete the second wave of courses at their own schedule and pace. GSA and PPAHS invite healthcare professionals, organizations, and patient advocates to join them in promoting sepsis awareness and improving outcomes for patients globally.
The Physician-Patie.
